Antiretroviral Activity and Safety of Once-Daily Etravirine in Treatment-Naive HIV-Infected Adults: 48-Week ResultsMichelle Floris-Moore, Joseph J. Eron, Catherine Kronk et al.|Antiviral Therapy|2015Cited by 6
Tenofovir/Emtricitabine Metabolites and Endogenous Nucleotide Exposures are associated with p16 <sup>INK4a</sup> Expression in Subjects on Combination TherapyJulie B. Dumond, Alan Forrest, Owen Francis et al.|Antiviral Therapy|2015Cited by 5
Tenofovir/emtricitabine metabolites and endogenous nucleotide exposures are associated with p16INK4a expression in subjects on combination therapyHeather Prince, Stephanie A. Malone, Christine Trezza et al.|UNC Libraries|2020Cited by 1
Antiretroviral activity and safety of once-daily etravirine in treatment-naive HIV-infected adults: 48-week resultsMarc A. Johnson, Kristine B. Patterson, Michelle Floris-Moore et al.|UNC Libraries|2020Cited by 0